Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eukaryotic Hyaluronan Synthase 1 (HAS1) | Login | Eukaryotic Hyaluronan Synthase 1 (HAS1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Salivary Alpha Amylase (AMY1A) | Login | Recombinant Salivary Alpha Amylase (AMY1A) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Salivary Alpha Amylase (AMY1A) | Login | Recombinant Salivary Alpha Amylase (AMY1A) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Amylase, Alpha 2A (AMY2A) | Login | Recombinant Amylase, Alpha 2A (AMY2A) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Amylase, Alpha 2A (AMY2A) | Login | Recombinant Amylase, Alpha 2A (AMY2A) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bone Marrow Stromal Cell Antigen 1 (BST1) | Login | Recombinant Bone Marrow Stromal Cell Antigen 1 (BST1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bone Marrow Stromal Cell Antigen 1 (BST1) | Login | Recombinant Bone Marrow Stromal Cell Antigen 1 (BST1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bone Marrow Stromal Cell Antigen 1 (BST1) | Login | Recombinant Bone Marrow Stromal Cell Antigen 1 (BST1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Pancreatic Elastase 1 (ELA1) | Login | Recombinant Pancreatic Elastase 1 (ELA1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Thrombopoietin Receptor (TPOR) | Login | Recombinant Thrombopoietin Receptor (TPOR) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Thrombopoietin Receptor (TPOR) | Login | Recombinant Thrombopoietin Receptor (TPOR) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 3 (Bcl3) | Login | Recombinant B-Cell CLL/Lymphoma 3 (Bcl3) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Chemokine (C-X-C Motif) Ligand 14 (CXCL14) | Login | Recombinant Chemokine (C-X-C Motif) Ligand 14 (CXCL14) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Chemokine (C-X-C Motif) Ligand 3 (CXCL3) | Login | Recombinant Chemokine (C-X-C Motif) Ligand 3 (CXCL3) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Interleukin 12 Receptor Beta 1 (IL12Rb1) | Login | Recombinant Interleukin 12 Receptor Beta 1 (IL12Rb1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Cluster Of Differentiation 146 (CD146) | Login | Recombinant Cluster Of Differentiation 146 (CD146) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Cluster Of Differentiation 146 (CD146) | Login | Recombinant Cluster Of Differentiation 146 (CD146) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Interleukin 12 Receptor Beta 1 (IL12Rb1) | Login | Recombinant Interleukin 12 Receptor Beta 1 (IL12Rb1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) | Login | Recombinant V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Actin Alpha 2, Smooth Muscle (ACTa2) | Login | Recombinant Actin Alpha 2, Smooth Muscle (ACTa2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Cytokeratin 20 (CK 20) | Login | Recombinant Cytokeratin 20 (CK 20) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) | Login | Recombinant V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Serpin B3 (SERPINB3) | Login | Recombinant Serpin B3 (SERPINB3) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) | Login | Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Cathepsin D (CTSD) | Login | Recombinant Cathepsin D (CTSD) | ||||||||||||||||
|
||||||||||||||||||


